Skip to main content

Table 1 Vaccination coverage rates of children aged 12-23 months in Uganda by sub-region (1995-2016)

From: Two decades of regional trends in vaccination completion and coverage among children aged 12-23 months: an analysis of the Uganda Demographic Health Survey data from 1995 to 2016

 

Kampala

1995 (n = 75)

2000 (n = 68)

2006 (n = 61)

2011 (n = 72)

2016 (n = 126)

Rate (%)

(95%CI)

Rate (%)

95%CI)

Rate (%)

95%CI)

Rate (%)

95%CI)

Rate (%)

95%CI)

Antigens

 BCG

95.3

87.7–98.3

94.1

85.5–97.7

90.1

75.9–96.3

94.8

82.6–98.6

99.2

94.9–99.9

 DPT3

78.9

65.0–88.2

58.8

47.0–69.7

68.3

59.1–76.2

76.5

62.3–86.5

79.9

72.1–85.9

 OPV3

70.6

60.8–78.8

61.8

50.0–72.3

54.8

45.8–63.5

75.7

66.4–83.1

57.5

47.6–66.9

 Measles

78.9

68.1–86.7

70.6

57.6–80.9

69.4

60.3–77.1

83.8

73.5–90.6

81.8

72.4–88.4

 All*

58.9

46.1–70.6

38.2

26.3–51.8

45.6

36.9–54.5

67.5

54.4–78.3

51.4

41.3–61.3

 

Central 1

1995 (n = 75)

2000 (n = 68)

2006 (n = 61)

2011 (n = 72)

2016 (n = 126)

Antigens

 BCG

82.6

72.4–89.6

55.6

43.9–66.7

73.9

65.8–80.7

88.4

78.5–94.1

93.3

88.7–96.0

 DPT3

70.6

59.3–79.8

23.5

15.9–33.2

51.8

42.7–60.8

70.1

56.7–80.7

74.5

67.8–80.3

 OPV3

68.3

58.4–76.7

26.1

17.2–37.3

53.3

44.2–62.1

56

44.6–66.7

63.8

56.5–70.5

 Measles

62.5

53.5–70.7

39.7

29.4–50.9

60.9

49.9–70.9

77.8

65.5–86.7

74.9

68.3–80.5

 All*

55.5

45.4–65.2

17.3

10.6–27.1

43.2

33.9–52.9

46.8

34.7–59.3

51.9

45.3–58.4

 

Central 2

1995 (n = 121)

2000 (n = 102)

2006 (n = 97)

2011 (n = 124)

2016 (n = 268)

Antigens

 BCG

85.9

78.1–91.3

71.8

62.4–79.6

88.2

78.4–93.9

95.4

89.1–98.1

94.8

89.6–97.5

 DPT3

69.3

60.3–77.0

39.9

30.0–50.8

64.8

52.9–75.2

58.6

48.4–68.1

76.4

68.5–82.8

 OPV3

67.7

58.2–76.0

43.2

34.6–52.8

61.3

49.1–72.2

53.8

40.7–66.3

57.2

49.0–65.1

 Measles

64.6

54.0–73.9

51.7

40.7–62.5

66.3

56.1–75.2

70.9

60.5–79.5

73

63.8–80.6

 All*

50.4

40.5–60.3

32.3

22.8–43.4

51.1

38.7–63.3

41.7

30.9–53.3

47.1

39.7–54.6

 

East central

1995 (n = 130)

2000 (n = 118)

2006 (n = 147)

2011 (n = 135)

2016 (n = 231)

Antigens

 BCG

75.3

64.7–83.5

79.9

70.2–87.0

88.2

81.7–92.6

96.3

92.3–98.2

97.1

92.3–98.9

 DPT3

41.2

33.2–49.8

36.4

23.5–51.6

59.4

48.6–69.3

53.0

44.0–61.7

71.2

63.1–78.1

 OPV3

36.8

27.4–47.4

45.6

32.1–59.7

53.2

45.0–61.2

53.1

45.2–60.9

57.0

47.2–66.3

 Measles

39.3

31.9–47.2

43.5

31.4–56.4

56.7

48.4–64.6

70.9

63.3–77.4

71.1

62.3–78.6

 All*

28.2

21.0–36.6

33.0

20.2–48.9

38.9

30.7–47.9

38.6

29.4–48.7

45.0

35.8–54.5

 

Eastern

1995 (n = 207)

2000 (n = 214)

2006 (n = 224)

2011 (n = 212)

2016 (n = 476)

Antigens

 BCG

84.5

77.9–89.4

85.9

79.4–90.6

95.5

91.0–97.8

97.0

92.7–98.8

98.5

97.1–99.2

 DPT3

53.9

45.5–62.1

50.8

38.7–62.8

67.2

57.7–75.4

75.4

67.1–82.1

81.7

77.6–85.2

 OPV3

53.1

44.9–61.1

65.3

54.6–74.6

63.2

53.4–72.0

61.0

50.4–70.6

66.8

62.3–71.0

 Measles

52.7

44.4–60.9

58.5

46.9–69.2

62.6

52.0–72.1

76.6

68.9–82.8

80.9

75.9–85.1

 All*

37.3

30.0–45.1

41.8

31.4–52.9

46.3

36.1–56.9

52.8

41.3–63.7

56.7

51.3–61.9

 

Northern

1995 (n = 138)

2000 (n = 67)

2006 (n = 172)

2011 (n = 115)

2016 (n = 258)

Antigens

 BCG

81.7

68.1–90.3

69.0

58.8–77.6

96.3

92.6–98.2

94.5

86.6–97.8

97.3

94.7–98.7

 DPT3

49.1

28.4–70.1

41.3

28.8–55.0

69.7

59.3–78.3

74.7

63.0–83.6

82.1

76.9–86.3

 OPV3

41.6

25.0–60.2

49.7

37.2–62.2

58.9

50.9–66.4

60.4

50.1–69.9

72.9

67.1–78.0

 Measles

57.7

40.7–73.1

47.2

32.6–62.2

80.2

71.2–86.9

70.4

56.7–81.2

77.6

71.7–82.5

 All*

37.0

21.2–56.1

29.1

20.3–39.7

48.5

39.4–57.7

48.3

37.1–59.7

57.5

51.1–63.7

 

Karamoja

1995 (n = 9)

2000 (n = 10)

2006 (n = 49)

2011 (n = 54)

2016 (n = 73)

Antigens

 BCG

58.2

36.8–76.8

100

95.9

90.3–98.3

99.9

99.4–100.0

98.8

93.1–99.8

 DPT3

25.3

4.2–72.5

81.1

43.7–95.9

65.9

49.0–79.4

92.6

84.0–96.7

87

80.1–91.7

 OPV3

25.3

4.2–72.5

95.3

70.7–99.4

64.6

49.0–77.7

67.9

60.2–81.6

79.2

68.6–86.8

 Measles

25.3

4.2–72.5

100

79.5

69.6–86.8

92.8

84.8–96.7

90.4

82.4–95.0

 All*

25.3

4.2–72.5

76.4

44.7–92.8

48.8

33.5–64.4

64.5

46.3–79.3

73.5

62.3–82.3

 

West Nile

1995 (n = 121)

2000 (n = 103)

2006 (n = 77)

2011 (n = 70)

2016 (n = 178)

Antigens

 BCG

85.9

75.0–92.5

85.3

75.3–91.7

96.2

91.5–98.3

98.3

93.7–99.6

95.4

90.5–97.9

 DPT3

47.2

38.4–56.2

50

39.5–60.5

59.4

48.9–69.1

81.3

71.3–88.4

83.0

76.8–87.8

 OPV3

45.6

37.9–53.5

61.9

47.7–74.3

57.1

46.8–66.8

63.0

49.4–74.8

74.8

67.4–80.9

 Measles

47.1

39.2–55.1

62.4

55.8–68.6

64.2

53.2–73.8

77.4

68.4–84.5

84.0

77.9–88.7

 All*

31.9

23.6–41.5

36.3

26.4–47.6

45.3

33.9–57.3

50.7

39.7–61.7

63.7

56.4–70.4

 

Western

1995 (n = 183)

2000 (n = 76)

2006 (n = 192)

2011 (n = 157)

2016 (n = 332)

Antigens

 BCG

84.5

74.1–91.2

78.7

66.6–87.3

91.9

85.4–95.7

94.6

88.2–97.6

95.8

92.7–97.6

 DPT3

76

63.5–85.3

50.6

33.3–67.8

71.9

61.0–80.8

77.4

65.4–86.1

76.9

72.5–80.8

 OPV3

76.3

63.9–85.3

54.6

38.8–69.5

67.3

57.3–75.9

71.9

58.1–82.6

67.4

62.3–72.1

 Measles

68.1

55.7–78.3

72.2

55.8–84.2

75.5

66.0–83.0

80.9

68.4–89.2

85.3

80.8–88.9

 All*

64

51.4–75.0

39

24.6–55.6

52.7

41.6–63.4

58.8

48.8–68.0

57.5

52.0–62.9

 

Southwest

1995 (n = 167)

2000 (n = 199)

2006 (n = 146)

2011 (n = 117)

2016 (n = 262)

Antigens

 BCG

85.3

77.5–90.7

82

72.0–88.9

86.6

77.8–92.5

87.8

82.3–91.8

97.1

94.2–98.6

 DPT3

71.5

61.8–79.5

60.3

51.2–68.7

62.8

51.2–73.1

79.4

71.4–85.6

87.0

81.2–91.1

 OPV3

74.2

64.3–82.1

66.2

58.2–73.4

46.7

55.3–73.1

80.3

72.4–86.4

77.1

70.7–82.5

 Measles

74.6

65.8–81.8

62.5

55.2–69.2

68.0

57.6–76.8

71.3

60.8–79.9

86.3

80.4–90.4

 All*

64.2

55.7–71.9

47.6

40.1–55.3

45.7

35.0–56.8

61.4

50.7–71.0

65.9

59.1–72.1

  1. * Completed vaccination: 1 dose of BCG vaccine; 3 doses of DPT vaccine; 3 doses of OPV (excluding OPV at birth); and 1 dose of measles vaccine